1
Zeevat, Florian, Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.
Veröffentlicht in: Zeevat , F , Wilschut , J C , Boersma , C & Postma , M J 2023 , ' Reducing Hospital Capacity Needs for Seasonal Respiratory Infections : The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults ' , Value in Health , vol. 26 , no. 4 , pp. 461-464 . https://doi.org/10.1016/j.jval.2022.11.020;
2023
Veröffentlicht in: Zeevat , F , Wilschut , J C , Boersma , C & Postma , M J 2023 , ' Reducing Hospital Capacity Needs for Seasonal Respiratory Infections : The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults ' , Value in Health , vol. 26 , no. 4 , pp. 461-464 . https://doi.org/10.1016/j.jval.2022.11.020;
2023
2
3
Westra, Tjalke A., Daemen, Toos, Postma, Maarten J., Wilschut, Jan C.
Veröffentlicht in: Westra , T A , Daemen , T , Postma , M J & Wilschut , J C 2009 , ' Doelmatigheid van humaan papillomavirus-vaccinatie : Schattingen op basis van Nederlandse kosteneffectiviteitanalyses ' , Nederlands Tijdschrift voor Geneeskunde , vol. 153 , no. 45 , A356 . < https://www.ntvg.nl/artikelen/doelmatigheid-van-humaan-papillomavirus-vaccinatie#:~:text=Tenslotte%20blijkt%20uit%20de%205,%E2%82%AC20.000%20per%20gewonnen%20QALY. >;
2009
Veröffentlicht in: Westra , T A , Daemen , T , Postma , M J & Wilschut , J C 2009 , ' Doelmatigheid van humaan papillomavirus-vaccinatie : Schattingen op basis van Nederlandse kosteneffectiviteitanalyses ' , Nederlands Tijdschrift voor Geneeskunde , vol. 153 , no. 45 , A356 . < https://www.ntvg.nl/artikelen/doelmatigheid-van-humaan-papillomavirus-vaccinatie#:~:text=Tenslotte%20blijkt%20uit%20de%205,%E2%82%AC20.000%20per%20gewonnen%20QALY. >;
2009
4
Zeevat, Florian, Dvortsin, Evgeni, Wondimu, Abrham, Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.
Veröffentlicht in: Zeevat , F , Dvortsin , E , Wondimu , A , Wilschut , J C , Boersma , C & Postma , M J 2021 , ' Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands : An Opportunity Lost ' , Vaccines , vol. 9 , no. 2 , 144 . https://doi.org/10.3390/vaccines9020144;
2021
Veröffentlicht in: Zeevat , F , Dvortsin , E , Wondimu , A , Wilschut , J C , Boersma , C & Postma , M J 2021 , ' Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands : An Opportunity Lost ' , Vaccines , vol. 9 , no. 2 , 144 . https://doi.org/10.3390/vaccines9020144;
2021
5
de Boer, Pieter T., Nagy, Lisa, Dolk, Franklin C. K., Wilschut, Jan C., Pitman, Richard, Postma, Maarten J.
Veröffentlicht in: de Boer , P T , Nagy , L , Dolk , F C K , Wilschut , J C , Pitman , R & Postma , M J 2021 , ' Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands ' , Value in Health , vol. 24 , no. 1 , pp. 19-31 . https://doi.org/10.1016/j.jval.2020.10.011;
2021
Veröffentlicht in: de Boer , P T , Nagy , L , Dolk , F C K , Wilschut , J C , Pitman , R & Postma , M J 2021 , ' Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands ' , Value in Health , vol. 24 , no. 1 , pp. 19-31 . https://doi.org/10.1016/j.jval.2020.10.011;
2021
6
Zeevat, Florian, Simons, Joost J.M., Westra, Tjalke A., Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.
Veröffentlicht in: Zeevat , F , Simons , J J M , Westra , T A , Wilschut , J C , Boersma , C & Postma , M J 2024 , ' Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach ' , Infectious diseases and therapy . https://doi.org/10.1007/s40121-023-00903-0;
2024
Veröffentlicht in: Zeevat , F , Simons , J J M , Westra , T A , Wilschut , J C , Boersma , C & Postma , M J 2024 , ' Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach ' , Infectious diseases and therapy . https://doi.org/10.1007/s40121-023-00903-0;
2024
7
Postma, Maarten J., Novak, Annoesjka, Scheijbeler, Huib W. K. F. H., Gyldmark, Marlene, van Genugten, Marianne L. L., Wilschut, Jan C.
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
Veröffentlicht in: Postma , M J , Novak , A , Scheijbeler , H W K F H , Gyldmark , M , van Genugten , M L L & Wilschut , J C 2007 , ' Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza - Illustration for the Netherlands ' , Pharmacoeconomics , vol. 25 , no. 6 , pp. 497-509 .;
2007
8
Setiawan, Didik, Luttjeboer, Jos, Westra, Tjalke Arend, Wilschut, Jan C., Suwantika, Auliya A., Daemen, Toos, Atthobari, Jarir, Wilffert, Bob, Postma, Maarten J.
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015
Veröffentlicht in: Setiawan , D , Luttjeboer , J , Westra , T A , Wilschut , J C , Suwantika , A A , Daemen , T , Atthobari , J , Wilffert , B & Postma , M J 2015 , ' The cost-effectiveness of HPV vaccination in addition to screening : a Dutch perspective ' , Expert review of vaccines , vol. 14 , no. 4 , pp. 589-604 . https://doi.org/10.1586/14760584.2014.990386;
2015
9
Eijsink, Job F. H., Al Khayat, Mohamed N. M. T., Boersma, Cornelis, ter Horst, Peter G. J., Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Eijsink , J F H , Al Khayat , M N M T , Boersma , C , ter Horst , P G J , Wilschut , J C & Postma , M J 2021 , ' Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 1 , pp. 75-88 . https://doi.org/10.1007/s10198-020-01236-2;
2021
Veröffentlicht in: Eijsink , J F H , Al Khayat , M N M T , Boersma , C , ter Horst , P G J , Wilschut , J C & Postma , M J 2021 , ' Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 1 , pp. 75-88 . https://doi.org/10.1007/s10198-020-01236-2;
2021
10